Table 2. Comparative analysis of patients with and without rebiopsy regarding measured variables.
2nd Biopsy | ||||
---|---|---|---|---|
No | Yes | |||
Number (%) | Number (%) | P | ||
Total Testosterone ng/dL | ||||
<231 ng/dL | 28(10) | 1(2.5) | 0.217** | |
231–346 ng/dL | 39(13.9) | 8(20) | ||
>346 ng/dL | 213(76.1) | 31(77.5) | ||
Mean(SD) | Mean(SD) | P | ||
Prostate Volume mL | 49.7(22.5) | 47.4(18.1) | 0.534* | |
Total Testosterone ng/dL | 410.9(145.2) | 423.6(120.3) | 0.597* | |
SHBG nmol/L | 49.9(20.8) | 50.4(18.4) | 0.873* | |
Free Testosterone ng/dL | 6.6(2.7) | 6.9(3.5) | 0.569* | |
Bioavaillable Testosterone ng/dL | 161.6(65.2) | 164.4(81.2) | 0.807* | |
Albumin g/dL | 4.5(0.3) | 4.5(0.2) | 0.640* |
Student's t-test
Chi-square test
SD = Standard Deviation